The Global Fund makes smart, effective investments in the fight against HIV, TB and malaria through a unique, partnership-based funding model.
The funding model, which continuously evolves based on new needs, learning and realities, recognizes the only way to end the three diseases as epidemics is by working together. This includes the Global Fund, governments, civil society, people affected by the diseases, technical partners, the private sector and other partners.
The funding model runs in three-year cycles that correspond with our donor Replenishment cycles. The upcoming funding cycle runs from 2020 through 2022, following the Replenishment Conference in October 2019.
In each funding cycle, the Global Fund allocates donor funds to eligible countries. Countries then apply for their funding after engaging in an inclusive consultation at the country level. After technical review and approval, countries implement their grants. Evaluation and oversight continues throughout implementation to monitor progress and performance.
At the beginning of the funding cycle, the Global Fund allocates funding to eligible countries for HIV, tuberculosis and malaria programs. This funding may also be used to strengthen health systems.
To access the funding, countries meet eligibility and other requirements outlined on this page.
Eligibility for Global Fund financing is determined by a country’s income level and disease burden. Countries may be eligible for funding for one, two or all three of the diseases.
See Eligibility for more information.